POST

High Aspirin Intake Can Save Diabetics from Heart Attacks

University of Alberta finds benefits in Aspirin Aspirin, when taken in high doses, can prevent or reduce the risk of heart attacks among those who are diabetic. The study was conducted by Canadian researchers and the results were found to be highly conclusive. Scot Simpson from the University of Alberta conducted the research. He headed Read more

POST

Reduce Side Effects of Cancer with Antibiotics

It is common for physicians to prescribe antibiotics to overcome a bacterial infection. In addition, antibiotics are effective to heal a cut that may become infected if not treated. However, prescribing antibiotics for cancer treatment is not very common. Although, antibiotics have been used since 1950s to treat cancer, the side effects prohibit long-term use Read more

POST

New Drug Treatment To Cut The Risk Of Heart Attack

In the present market a new clot-busting drug has approved in order to use in NHS, which is quite be able to cut the risk of dying after heart attack. In this drug Brilique has taken along with aspirin, which is much more suitable for those people who have been admitted to a hospital after Read more

POST

Hospitals Now Put Patients In Quarantine Box Using Duct Tape

In hospital cases where a serious infection is present the current requirement is patient isolation. For any medical personnel or family to enter the isolation environment, they must don paper or plastic gowns and gloves, and in some cases masks and shoe covers, all of which are disposable and not meant for more than single Read more

POST

Pine Bark Could Augment Heart Function, Study Finds

According to the latest study published in Panminerva Medica, natural supplement Pycnogenol along with Coenzyme Q10 together can improve heart functions to great extents. The combination aids in improving the heart health, physical fitness, blood volume output, respiratory and heart rate and blood pressure.

POST

PreDx DRS Helps in Determining Risk of Developing Diabetes 5 years From Now

Data collected after analyzing samples from European Diabetes Prevention Study (EDIPS) have shown that the PreDx Diabetes Risk Score (DRS) is significantly lowered by lifestyle intervention. This indicates that the person has low risks of developing diabetes in the future. The same data has also shown that people with very high DRS, i.e. those at Read more

POST

Brain study could help in detecting autism in children

Dr. Ilan Dinstein and his team of doctors and researchers from Weizmann Institute of Science in Rehovot, Israel found a new study that states that early signs of weaker synchronization of right and left sides of the brain of a child could help in detecting Autism in toddlers. Children with this condition show weaker harmonization Read more

POST

Instilling Healthy Habits Can Curb Obesity in Children and Babies

The common perception that chubbiness in the newly born is the sign of great health and strength as the baby grow but in certain cases, bigger babies can never lose their baby weight and build a road towards obesity. Here comes the role and duty of the parties to inculcate healthy behavioral habit in their Read more

POST

Studies show Victoza Helps Reduce Blood Sugar Levels of Patients with Type2 Diabetes

At the 71st Annual Scientific sessions of the American Diabetes Association, Novo Nordisk is going to present data from two studies. The data will show that Victoza (liraglutide [rDNA origin] injection), helped patients in bringing blood sugar levels to normal. Though, Victoza is not a weight loss product but still the patients experienced weight loss Read more

POST

Genome Editing Found as the Precise Cure for Hemophilia in Mice

A new gene therapy has been developed which brought the level of blood clotting to the normal level in mice suffering with hemophilia. Hemophilia is a disease which renders the body unable to control the coagulation of blood. The body stops producing a protein which triggers the clotting of blood. Due to this any cut Read more

POST

FDA Recommends Reduced Dosage of ESAs For Chronic Kidney Disease Treatments

The Food and Drug Administration (FDA) recommended lower dosage to check the cardiovascular events related to Erythropoiesis-Stimulating Agents (ESAs) which are used in anemia treatment for patients with chronic kidney diseases. Stroke, thrombosis and even death are the cardiovascular effects related to the dosing.

POST

Remarkable Role of Drug Telaprevir in Hepatitis C Treatment

Hepatitis C, the most common form of hepatitis which affects almost 170-180 million people world wide caused by the infectous agent HCV (hepatitis C Virus) finds hope in the drug Telaprevir said a team of researchers led by Dr. Ira M. Jacobson (Newyork Presbyterian Hospital).The U.S. FDA gave approval to telaprevir to be used on Read more